SecBot SecBot
PRESS-RELEASE ·Filed Oct 29, 2026

KYMR

Kymera Therapeutics, Inc.
BEARISH
Impact 5/10
Processed1h 45m ago Wirepress-3391085
Press release · Earnings

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3391085
36 reports for KYMR
Performance horizon
58% Hit rate @ T+20 7 of 12 directional calls Went positive at some point 8 of 12 best @ T+60▲ +60.99%Jun 8, 2026
Filters
Rows
Reports for KYMR, sortable and filterable
TypeNow
Oct 29, 2026
today
8-K
NEUTRAL ★ 5/10
$116.17awaiting T+20awaiting T+20$122.51 (+5.46%)
Oct 29, 2026
today
Press Release
BEARISH ★ 5/10
$124.80awaiting T+20awaiting T+20$122.51 (+1.83%)
Oct 28, 2026
today
Press Release
NEUTRAL ★ 5/10
$123.00awaiting T+20awaiting T+20$122.51 (−0.40%)
Oct 27, 2026
1d ago
Institutional Cluster
BULLISH ★ 4/10
$116.18awaiting T+20awaiting T+20$122.51 (+5.45%)
Oct 27, 2026
1d ago
SC 13G/A
NEUTRAL ★ 3/10
$114.15awaiting T+20awaiting T+20$122.51 (+7.32%)
Oct 22, 2026
6d ago
Press Release
NEUTRAL ★ 1/10
$110.85awaiting T+20awaiting T+20$122.51 (+10.52%)
Aug 5, 2026
12w ago
8-K
BULLISH ★ 6/10
$105.48 $118.63▲ +12.47%▲ +13.07%$122.51 (+16.15%)
Jul 7, 2026
16w ago
Insider Cluster
BEARISH ★ 5/10
$114.16 $105.48▲ +7.60%▲ +10.88%$122.51 (−7.31%)
Jul 2, 2026
16w ago
Insider Cluster
BEARISH ★ 5/10
$114.76 $100.31▲ +12.59%▲ +13.44%$122.51 (−6.75%)
Jul 2, 2026
16w ago
Insider Cluster
BEARISH ★ 6/10
$113.51 $107.01▲ +5.73%▲ +5.31%$122.51 (−7.93%)
Showing 10 of 36

US Market Status

Market Closed · Opens in 44m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 29, 2026

Fresh KYMR Intelligence

Analysis is for subscribers only.

Subscribe for Full Access